未找到相关数据
Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis.
被引：3
作者：
Yu, Kenneth H.
Mantha, Simon
Tjan, Catherine
Kaufmann, Erica S.
Brenner, Robin
Lowery, Maeve Aine
Ku, Geoffrey Yuyat
Raj, Nitya Prabhakar
Shcherba, Marina
Goldberg, Zoe
Li, Jia
Zervoudakis, Alice
Hamilton, Audrey M.
Won, Elizabeth
Ucar, Antonio
Do, Richard K. G.
O'Reilly, Eileen Mary
机构：
[1] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Albert Einstein Coll Med, Springfield, NJ USA
[4] Mem Sloan Kettering Canc Ctr, Rockville, MD USA
[5] Yale Univ, Yale Sch Med, New Haven, CT USA
[6] Winthrop Oncol Hematol Associates, Mineola, NY USA
[7] Memor Sloan Kettering Canc Ctr, Basking Ridge, NJ USA
[8] Memor Sloan Kettering Canc Ctr, New York, NY USA
[9] Adv Med Specialists, Miami, FL USA
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
405
引用
收藏
页数：1
相关论文